乳腺癌耐药蛋白（breast cancer resistance protein,BCRP）是一种重要的ABC外排转运体,在大多数组织和器官中都有表达,发挥对机体组织的保护作用。
基于94个网页-相关网页
目的研究P-糖蛋白(P-glycoprotein,P-gp)、乳腺癌耐药蛋白(breast cancer drug resistance protein,BCRP)和肺耐药蛋白( ..
基于8个网页-相关网页
和乳腺癌耐药蛋白 breast cancer resistant protein
与乳腺癌耐药蛋白 BCRP ; breast cancer resistance protein
乳腺癌耐药蛋白基因 BCRP ; Breast cancer resistance protein gene
乳腺癌耐药相关蛋白 breast cancer resistance protein ; BCRP
对乳腺癌耐药相关蛋白 breast cancer resistance protein
目的研究乳腺癌耐药蛋白(BCRP)基因在乳腺癌组织中的表达水平，探讨其与肿瘤病理分期、淋巴结转移的关系。
Objective to study the expression levels of breast cancer resistance protein (BCRP) in breast cancer, and to investigate the relation between BCRP and clinical stages and lymph node metastasis.
因此，乳腺癌多药耐药蛋白有望成为一种新的治疗靶点。
So, the breast cancer resistance protein will be the new therapeutic target.
目的探讨肺耐药蛋白对常规化疗后乳腺癌患者的预后影响。
Objective:To investigate The influence of breast carcinomas prognosis on LRP after treated convention chemotherapies.
应用推荐